Show simple item record

dc.contributor.authorMoos, Walter H.en_US
dc.contributor.authorFaller, Douglas V.en_US
dc.contributor.authorGlavas, Ioannis P.en_US
dc.contributor.authorHarpp, David N.en_US
dc.contributor.authorKanara, Iphigeniaen_US
dc.contributor.authorPinkert, Carl A.en_US
dc.contributor.authorPowers, Whitney R.en_US
dc.contributor.authorSampani, Konstantinaen_US
dc.contributor.authorSteliou, Kostaen_US
dc.contributor.authorVavvas, Demetrios G.en_US
dc.contributor.authorKodukula, Krishnaen_US
dc.contributor.authorZamboni, Robert J.en_US
dc.date.accessioned2020-05-15T15:55:51Z
dc.date.issued2019-09
dc.identifier.citationWalter H Moos, Douglas V Faller, Ioannis P Glavas, David N Harpp, Iphigenia Kanara, Carl A Pinkert, Whitney R Powers, Konstantina Sampani, Kosta Steliou, Demetrios G Vavvas, Krishna Kodukula, Robert J Zamboni. 2019. "Epigenetic treatment of dermatologic disorders." Drug Development Research, Volume 80, Issue 6, pp. 702 - 713. https://doi.org/10.1002/ddr.21562
dc.identifier.issn0272-4391
dc.identifier.issn1098-2299
dc.identifier.urihttps://hdl.handle.net/2144/40917
dc.descriptionPlease note: this work is permanently embargoed in OpenBU. No public access is forecasted for this item. To request private access, please click on the locked Download file link and fill out the appropriate web form.en_US
dc.description.abstractHealthy skin protects us against a multitude of insults but injured or maladapted skin can lead to infection, inflammation or worse. Fortunately, naturally occurring bioactive products, many commonly found in olive oil and other plant and vegetable extracts,have shown utility in treating skin and related diseases as well as conditioning the skin to maintain its healthy function. Powerful agents targeting nuclear regulatory pathways continue to hold promise as new or repurposed therapies for a wide variety of ills and skin conditions. Epigenetic approaches that activate Nrf2 to effect detoxification, redox balance, DNA repair and mitochondrial function are noteworthy. Some of the disease applications being actively investigated range from eczema and psoriasis to skin cancer and diabetes-related wound healing to name just a fewen_US
dc.format.extentp. 702 - 713en_US
dc.languageen
dc.language.isoen_US
dc.publisherWileyen_US
dc.relation.ispartofDrug Development Research
dc.subjectDiabetesen_US
dc.subjectEpigeneticen_US
dc.subjectMicrobiomeen_US
dc.subjectMitochondrial dysfunctionen_US
dc.subjectSkin diseasesen_US
dc.subjectPharmacology & pharmacyen_US
dc.subjectPharmacology and pharmaceutical sciencesen_US
dc.titleEpigenetic treatment of dermatologic disordersen_US
dc.typeArticleen_US
dc.description.versionAccepted manuscripten_US
dc.identifier.doi10.1002/ddr.21562
dc.description.embargo2031-01-01
pubs.elements-sourcecrossrefen_US
pubs.notesOther: embargo indefinitelyen_US
pubs.organisational-groupBoston Universityen_US
pubs.organisational-groupBoston University, Administrationen_US
pubs.organisational-groupBoston University, School of Medicineen_US
pubs.publication-statusPublisheden_US
dc.date.online2019-07-04
dc.identifier.orcid0000-0002-5530-3194 (Steliou, Kosta)
dc.identifier.mycv489333


This item appears in the following Collection(s)

Show simple item record